miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 15, 2026

Morgan Stanley outlines path to $10T-plus client assets and sustained 20%+ ROTCE through market cycles

View original at seekingalpha.com
Morgan Stanley outlines path to $10T-plus client assets and sustained 20%+ ROTCE through market cycles Earnings Call Insights: Morgan Stanley (MS) Q4 2025 MANAGEMENT VIEW * CEO Ted Pick opened with, "In 2025, the U.S…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Equitization of markets around the world is underway; institutional trading wallet could continue to grow 5-10% per annum

    80% confidence
  • No philosophical frame shift on targets; firm now has confidence to discuss performance in more challenging environments with ability to still generate 17.5% ROTCE with earnings below $8

    80% confidence
  • This is not the time to overreach, emphasizing disciplined approach to capital deployment and M&A

    80% confidence
  • 2026 starts with the tailwinds of constructive fiscal policy and easier monetary policy

    80% confidence
  • Looking ahead to Q1 2026, NII expected to remain roughly flat quarter-over-quarter as higher average sweeps and lending balances offset the full impact of two rate cuts in Q4

    80% confidence
  • 2025 was an exceptional year for Morgan Stanley marked by deliberate execution of strategy

    80% confidence
  • Morgan Stanley is monetizing capital markets green shoots across investment banking and markets verticals, and scaling asset inflows and transaction activity across wealth businesses

    80% confidence
  • For remainder of 2026, assuming current forward curve, incremental loan growth and deposit mix projections, NII expected to continue to trend higher

    80% confidence
  • Targets will be revisited later in the year; if clearly passed through, they will consider taking them higher

    80% confidence
  • Morgan Stanley gained 100 basis points of wallet share in Institutional Securities

    80% confidence
  • Firm is focused on compounding earnings through the cycle rather than overreaching

    80% confidence
  • Growth plans embed the increasing adoption of AI tools throughout the enterprise and inside client base

    80% confidence
  • If there are lower asset prices due to drawdown, economic blip, or geopolitical event, there could be lower levels of performance

    80% confidence
  • If environment is welcoming, firm expects to execute at or above firmwide goals as in 2025; when backdrop is more challenged, aim to achieve higher lows

    80% confidence
  • In 2025, the U.S. economy proved resilient with well-capitalized corporates and higher-end consumers driving the economy forward

    80% confidence
  • Wealth Management margin expansion driven by building out fee-based revenues and fee-based assets, plus efficiency through technology

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Morgan Stanley outlines path to $10T-plus client assets and sustained 20%+ ROTCE through market cycles — Source | Via News | es.VIA.NEWS